Jeff Hansen

Jeff Hansen

| This email address is being protected from spambots. You need JavaScript enabled to view it.

Research Editor

jeffhans@uab.edu • (205) 209-2355

Communicates UAB research discoveries and initiatives from across the university for a variety of audiences.

Specific beats include: biochemistry; cell, developmental and integrated biology; microbiology; molecular genetics; neurobiology; pathology; pharmacology and tocixology; Alabama Drug Discovery Alliance; Bill L. Harbert Institute for Innovation and Entrepreneurship.

Learning how sensory organs in the skin work may solve sensory disorders, including pain seen in inflammation, diabetes and cancer treatment.
UAB and UMass researchers have uncovered a new mechanistic understanding of potential treatment for genetic disorders.
The collaboration among UAB, University of Wisconsin and Duke University will use bioengineered stem cells and bioengineered tissue to treat heart failure after heart attacks.
Improved production of stem cells is vital if they are to achieve their promise for medical research and disease treatments like transplantation, creating patient-specific cell-replacement therapies to treat neurological diseases, heart ailments, blood diseases and diabetes.

Computing challenges are found across the UAB campus, from physics and neurology to genetics and the microbiome. Alabama’s most advanced supercomputer is now at UAB, making it possible to solve these challenges. 

A UAB study that is the first of its kind found that a tiny RNA — miR-124-3p — appears to play a role in producing major depression. 

Coating insulin-producing cell-clusters with a thin protective layers may be a way to modify and use pig tissue to ultimately treat human diabetes. Testing in mice is the next step.

This NIH-funded conference is part of UAB’s effort to engage and retain neuroscience graduate students from underrepresented ethnic and racial groups across the United States.

This is the second potential diagnostic application for an investigational biomarker, and discussions are underway with industry partners to develop an assay from this UAB technology.

For a second summer, Maria Onatunde traveled to UAB from Florida to participate in UAB's PARAdiGM program, which offers in-depth research experience for undergraduates from disadvantaged and minority backgrounds.
Page 34 of 43